Insulin Resistance and Cardiometabolic Health
Michael Schubert, PhD
Michael McPhaul, MD, discusses advances in insulin resistance testing
The CREDENCE trial demonstrated how canagliflozin treatment brought down the levels of cardiorenal blood biomarkers